Febuxostat Hypersensitivity

被引:32
作者
Abeles, Aryeh M. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Med, Div Rheumatol, Farmington, CT 06030 USA
关键词
ALLOPURINOL; GOUT;
D O I
10.3899/jrheum.111161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:659 / 660
页数:2
相关论文
共 6 条
[1]   CELL-MEDIATED-IMMUNITY IN ALLOPURINOL-INDUCED HYPERSENSITIVITY [J].
BRADEN, GL ;
WARZYNSKI, MJ ;
GOLIGHTLY, M ;
BALLOW, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (02) :145-151
[2]   Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions [J].
Chohan, Saima .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (09) :1957-1959
[3]   SEVERE ALLOPURINOL TOXICITY - DESCRIPTION AND GUIDELINES FOR PREVENTION IN PATIENTS WITH RENAL-INSUFFICIENCY [J].
HANDE, KR ;
NOONE, RM ;
STONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :47-56
[4]   SEVERE HYPERSENSITIVITY REACTIONS ASSOCIATED WITH ALLOPURINOL [J].
MILLS, RM .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 216 (05) :799-&
[5]   Gout medication treatment patterns and adherence to standards of care from a managed care perspective [J].
Sarawate, CA ;
Brewer, KK ;
Yang, WY ;
Patel, PA ;
Schumacher, HR ;
Saag, KG ;
Bakst, AW .
MAYO CLINIC PROCEEDINGS, 2006, 81 (07) :925-934
[6]   Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment [J].
Stamp, Lisa K. ;
O'Donnell, John L. ;
Zhang, Mei ;
James, Jill ;
Frampton, Christopher ;
Barclay, Murray L. ;
Chapman, Peter T. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (02) :412-421